On Nov. 8, 2024, Anixa Biosciences announced updated positive data from the Phase 1 clinical trial of its…
On Oct. 4, 2024, researchers from Oxford university announced they had been awarded funding from Cancer Research UK…
On Aug. 31, 2023, 23andMe, a leading human genetics and biopharmaceutical company, today announced the Company has received…
On Mar. 6, 2018, the U.S. Food and Drug Administration (FDA) authorized 23andMe’s Personal Genome Service Genetic Health…
On May 19, 2016, President Barack Obama presented Mary-Claire King, Ph.D., a University of Washington professor of medicine…
On Sept. 8, 2014, the University of Washington and UW Medicine announced that Mary-Claire King, UW professor of…
On May 24, 2001, Dr. Eldon Jupe and a team of Oklahoma Medical Research Foundation (OMRF) researchers found…
In 1995, scientists cloned the tumor suppressor genes BRCA1 and BRCA2, inherited genetic mutations that can predict an…
In 1995, Mary-Claire King, an internationally known human geneticist, was recruited to the University of Washington’s (UW) School…
On Oct. 7, 1994, a strong candidate for the 17q-linked BRCA1 gene, which influences susceptibility to breast and…
In 1990, Geneticist Mary-Claire King and her colleagues at the University of California, Berkeley (UC Berkeley) discovered BRCA1,…